169 related articles for article (PubMed ID: 25362531)
41. Development of a soy food frequency questionnaire to estimate isoflavone consumption in US adults.
Kirk P; Patterson RE; Lampe J
J Am Diet Assoc; 1999 May; 99(5):558-63. PubMed ID: 10333777
[TBL] [Abstract][Full Text] [Related]
42. Chemopreventive effects of soy protein and purified soy isoflavones on DMBA-induced mammary tumors in female Sprague-Dawley rats.
Constantinou AI; Lantvit D; Hawthorne M; Xu X; van Breemen RB; Pezzuto JM
Nutr Cancer; 2001; 41(1-2):75-81. PubMed ID: 12094632
[TBL] [Abstract][Full Text] [Related]
43. Genistein, a soy isoflavone, up-regulates expression of antioxidant genes: involvement of estrogen receptors, ERK1/2, and NFkappaB.
Borrás C; Gambini J; Gómez-Cabrera MC; Sastre J; Pallardó FV; Mann GE; Viña J
FASEB J; 2006 Oct; 20(12):2136-8. PubMed ID: 16966488
[TBL] [Abstract][Full Text] [Related]
44. Enhancement of β-secretase inhibition and antioxidant activities of tempeh, a fermented soybean cake through enrichment of bioactive aglycones.
Ahmad A; Ramasamy K; Majeed AB; Mani V
Pharm Biol; 2015 May; 53(5):758-66. PubMed ID: 25756802
[TBL] [Abstract][Full Text] [Related]
45. Identification and quantification of daidzein-7-glucuronide-4'-sulfate, genistein-7-glucuronide-4'-sulfate and genistein-4',7-diglucuronide as major metabolites in human plasma after administration of kinako.
Hosoda K; Furuta T; Yokokawa A; Ishii K
Anal Bioanal Chem; 2010 Jun; 397(4):1563-72. PubMed ID: 20437034
[TBL] [Abstract][Full Text] [Related]
46. In vitro effects of soy phytoestrogens on rat L6 skeletal muscle cells.
Jones KL; Harty J; Roeder MJ; Winters TA; Banz WJ
J Med Food; 2005; 8(3):327-31. PubMed ID: 16176142
[TBL] [Abstract][Full Text] [Related]
47. Clinical characteristics and pharmacokinetics of purified soy isoflavones: multiple-dose administration to men with prostate neoplasia.
Fischer L; Mahoney C; Jeffcoat AR; Koch MA; Thomas BE; Valentine JL; Stinchcombe T; Boan J; Crowell JA; Zeisel SH
Nutr Cancer; 2004; 48(2):160-70. PubMed ID: 15231450
[TBL] [Abstract][Full Text] [Related]
48. The intracellular metabolism of isoflavones in endothelial cells.
Toro-Funes N; Morales-Gutiérrez FJ; Veciana-Nogués MT; Vidal-Carou MC; Spencer JP; Rodriguez-Mateos A
Food Funct; 2015 Jan; 6(1):98-108. PubMed ID: 25410768
[TBL] [Abstract][Full Text] [Related]
49. Estrogen receptor-β mediates the inhibition of DLD-1 human colon adenocarcinoma cells by soy isoflavones.
Bielecki A; Roberts J; Mehta R; Raju J
Nutr Cancer; 2011; 63(1):139-50. PubMed ID: 21161820
[TBL] [Abstract][Full Text] [Related]
50. Concentrations of isoflavones in macaques consuming standard laboratory monkey diet.
Stroud FC; Appt SE; Wilson ME; Franke AA; Adams MR; Kaplan JR
J Am Assoc Lab Anim Sci; 2006 Jul; 45(4):20-3. PubMed ID: 16884174
[TBL] [Abstract][Full Text] [Related]
51. Current knowledge and future direction of research on soy isoflavones as a therapeutic agents.
Kalaiselvan V; Kalaivani M; Vijayakumar A; Sureshkumar K; Venkateskumar K
Pharmacogn Rev; 2010 Jul; 4(8):111-7. PubMed ID: 22228950
[TBL] [Abstract][Full Text] [Related]
52. Androgen receptor and soy isoflavones in prostate cancer.
Sivoňová MK; Kaplán P; Tatarková Z; Lichardusová L; Dušenka R; Jurečeková J
Mol Clin Oncol; 2019 Feb; 10(2):191-204. PubMed ID: 30680195
[TBL] [Abstract][Full Text] [Related]
53. Anti-obesity molecular mechanism of soy isoflavones: weaving the way to new therapeutic routes.
Wang S; Wang Y; Pan MH; Ho CT
Food Funct; 2017 Nov; 8(11):3831-3846. PubMed ID: 29043346
[TBL] [Abstract][Full Text] [Related]
54. Daidzein and its Effects on Brain.
Ahmed T; Javed S; Tariq A; Budzyńska B; D'Onofrio G; Daglia M; Nabavi SF; Nabavi SM
Curr Med Chem; 2017; 24(4):365-375. PubMed ID: 27804870
[TBL] [Abstract][Full Text] [Related]
55. Prostate cancer metastasis and soy isoflavones: a dogfight over a bone.
Ajdžanovic V; Filipovic B; Miljic D; Mijatovic S; Maksimovic-Ivanic D; Miler M; Živanovic J; Miloševic V
EXCLI J; 2019; 18():106-126. PubMed ID: 30956643
[TBL] [Abstract][Full Text] [Related]
56. The role of isoflavones in cancer chemoprevention.
Sarkar FH; Li Y
Front Biosci; 2004 Sep; 9():2714-24. PubMed ID: 15353308
[TBL] [Abstract][Full Text] [Related]
57. From Proteomics to Personalized Medicine: The Importance of Isoflavone Dose and Estrogen Receptor Status in Breast Cancer Cells.
Ilieș M; Uifălean A; Pașca S; Dhople VM; Lalk M; Iuga CA; Hammer E
J Pers Med; 2020 Dec; 10(4):. PubMed ID: 33352803
[TBL] [Abstract][Full Text] [Related]
58. Effect of soy isoflavones on the growth of human breast tumors: findings from preclinical studies.
Kwon Y
Food Sci Nutr; 2014 Nov; 2(6):613-22. PubMed ID: 25493176
[TBL] [Abstract][Full Text] [Related]
59. Transcriptomic analysis identifies gene networks regulated by estrogen receptor α (ERα) and ERβ that control distinct effects of different botanical estrogens.
Gong P; Madak-Erdogan Z; Li J; Cheng J; Greenlief CM; Helferich W; Katzenellenbogen JA; Katzenellenbogen BS
Nucl Recept Signal; 2014; 12():e001. PubMed ID: 25363786
[TBL] [Abstract][Full Text] [Related]
60. Equol, an isoflavone metabolite, regulates cancer cell viability and protein synthesis initiation via c-Myc and eIF4G.
de la Parra C; Borrero-Garcia LD; Cruz-Collazo A; Schneider RJ; Dharmawardhane S
J Biol Chem; 2015 Mar; 290(10):6047-57. PubMed ID: 25593313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
